MarketCap
Facebook
X
TelegramAnnual report 2022
added 10-07-2022
Allied Healthcare Products DSO Ratio 2011-2026 | AHPI
Annual DSO Ratio Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 | 162 | 103 | 37 | 40.7 | 36.8 | 41.7 | 36.9 | 37.4 | 40.3 | 41.1 | 42.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 162 | 36.8 | 65 |
Quarterly DSO Ratio Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 33.3 | 36.8 | 37.4 | 39.5 | 39.2 | 28.7 | 28.6 | 27.7 | 37 | 38.1 | 36.3 | 39.5 | 37.6 | 37.3 | 43.6 | 42.2 | 39.5 | 36.7 | 39.3 | 18.5 | 35.2 | 35.8 | 39.5 | 45.2 | 42.2 | 37.5 | 38.4 | 36.9 | 36.9 | 34.7 | 37.6 | 37.6 | 37.2 | 37.1 | 41.1 | 44 | 40.7 | 33.4 K | 42.6 K | 45.1 | 44.5 | 40 | 42.1 | 45.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 42.6 K | 18.5 | 1.76 K |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Butterfly Network
BFLY
|
76.1 | $ 4.19 | - | $ 887 M |  USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 9.51 | - | $ 269 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Establishment Labs Holdings
ESTA
|
123 | $ 59.61 | - | $ 1.77 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
38.2 | $ 82.02 | - | $ 48 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 2.06 | - | $ 1.25 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 9.43 | - | $ 726 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 13.73 | - | $ 887 M |  Israel |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 1.35 | - | $ 21.8 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 34.86 | - | $ 5.19 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
LivaNova PLC
LIVN
|
53.8 | $ 63.24 | - | $ 3.45 B |  Britain |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Medtronic PLC
MDT
|
68.8 | $ 87.17 | - | $ 112 B | USA |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
Myomo
MYO
|
35.3 | $ 0.71 | - | $ 29.7 M | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 12.15 | - | $ 1.82 B | USA |
 |
Delcath Systems
DCTH
|
48.5 | $ 9.1 | - | $ 326 M | USA |
 |
Orthofix Medical
OFIX
|
60 | $ 11.87 | - | $ 470 M |  Curacao |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Penumbra
PEN
|
46.5 | $ 335.56 | - | $ 13.1 B | USA |
 |
AxoGen
AXGN
|
40.7 | $ 31.75 | - | $ 1.46 B | USA |
 |
CONMED Corporation
CNMD
|
64.5 | $ 36.63 | - | $ 1.14 B | USA |
 |
Insulet Corporation
PODD
|
40.7 | $ 227.08 | - | $ 16 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Quanterix Corporation
QTRX
|
81.6 | $ 3.94 | - | $ 168 M | USA |
 |
Electromed
ELMD
|
137 | $ 24.49 | - | $ 207 M | USA |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
67 | $ 2.55 | - | $ 7.07 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.67 | - | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.3 | - | $ 3.59 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Tactile Systems Technology
TCMD
|
49.2 | $ 26.51 | - | $ 606 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 10.37 | - | $ 1.4 B | USA |
 |
IRadimed Corporation
IRMD
|
52.7 | $ 99.2 | - | $ 1.26 B | USA |
 |
FONAR Corporation
FONR
|
237 | $ 18.34 | -0.22 % | $ 120 M | USA |